Aspira Women's Health Inc.SEC Filings
|
|
All SEC filings by Aspira Women's Health Inc. (AWHL) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 14, 2026 | |
| 10-Q | Quarterly report | View Diff | May 15, 2026 | |
| ARS | Annual report to shareholders | Apr 29, 2026 | ||
| 10-K | Annual report | View Diff | Apr 1, 2026 | |
| NT 10-K | Notice of late annual filing | Apr 1, 2026 | ||
| 10-Q | Quarterly report | View Diff | Nov 14, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 12, 2025 | |
| 10-Q | Quarterly report | View Diff | May 19, 2025 | |
| NT 10-Q | Notice of late quarterly filing | May 15, 2025 | ||
| ARS | Annual report to shareholders | Apr 14, 2025 |
Events
| 8-K | Current report | Jul 15, 2026 | ||
| 8-K/A | Current report | Jul 7, 2026 | ||
| 8-K | Current report | Jun 22, 2026 | ||
| 8-K | Current report | Jun 17, 2026 | ||
| 8-K | Current report | Jun 9, 2026 | ||
| 8-K | Aspira Women’s Health and Cleveland Clinic Expand Strategic Collaboration to Advance Ai-Powered Diagnostics in Women’s Health | May 26, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Apr 30, 2026 | ||
| 8-K/A | Entry Into a Material Definitive Agreement | Mar 25, 2026 | ||
| 8-K | Entry Into a Material Definitive Agreement | Jan 30, 2026 | ||
| 8-K | Regulation Fd Disclosure | Dec 31, 2025 |
Registrations and Prospectuses
| D | Exempt offering of security | Jun 22, 2026 | ||
| 424B3 | Prospectus supplement | Jan 9, 2026 | ||
| S-1 | IPO registration | View Diff | Dec 31, 2025 | |
| 424B3 | Prospectus supplement | Nov 21, 2025 | ||
| S-1/A | IPO registration | View Diff | Oct 20, 2025 | |
| S-1 | IPO registration | View Diff | Sep 30, 2025 | |
| D | $2.95 Mm in Equity / Options / Securities to Be Acquired, Sold $2.95 Mm, 19 Investors | Sep 18, 2025 | ||
| S-8 | Registration of securities for employees | Jun 9, 2025 | ||
| 424B3 | Prospectus supplement | May 7, 2025 | ||
| S-1/A | IPO registration | View Diff | May 6, 2025 |
Proxies
| DEFA14A | Additional proxy soliciting materials | May 29, 2026 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 28, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 24, 2026 | |
| DEFR14A | Revised proxy | Apr 22, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 11, 2025 | |
| PRE 14A | Preliminary proxy | View Diff | Mar 31, 2025 | |
| DEFA14A | Additional proxy soliciting materials | May 9, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 29, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 29, 2024 | |
| DEFA14A | Additional proxy soliciting materials | Apr 3, 2023 |
Other
| EFFECT | Notice of effectiveness | Jan 12, 2026 | ||
| CORRESP | Correspondence with SEC | Jan 7, 2026 | ||
| UPLOAD | Letter from SEC | Jan 6, 2026 | ||
| EFFECT | Notice of effectiveness | Nov 24, 2025 | ||
| CORRESP | Correspondence with SEC | Nov 19, 2025 | ||
| EFFECT | Notice of effectiveness | May 8, 2025 | ||
| CORRESP | Correspondence with SEC | May 6, 2025 | ||
| CORRESP | Correspondence with SEC | May 6, 2025 | ||
| CORRESP | Correspondence with SEC | Apr 30, 2025 | ||
| UPLOAD | Letter from SEC | Apr 22, 2025 |